Vetnuus | Februarie 2024 18 « BACK TO CONTENTS prevent phagocytic clearing and promote mucosal colonization of the lower respiratory tract in humans. In contrast to the serotype A capsule, the serotype B polysaccharide capsule consists of arabinose, mannose, and galactose sugar residues with as-yetunclear linkages (427). The cexA gene, a homolog of hexA, is part of a 15-gene capsule (cap) biosynthesis locus and has been shown to be a virulence determinant for P. multocida strain M1404 (serotype B:2) in mice (426). Serotype B and E isolates are infrequently recovered from human infections (239). Based on sensitivity to mucopolysaccharidases, structural composition analysis, and cloning and sequencing of the capsule biosynthesis genes, serotype D capsules are comprised of heparin or heparin sulfate (101, 102, 430), and serotype F capsules are made of chondroitin (101, 430, 431). The capsule biosynthesis gene loci for serotypes A, D, and F appear to have high similarity with each other but can be distinguished by multiplex PCR-based typing analysis (106, 118). Human clinical isolates with serotype D capsules are most often associated with systemic infections resulting from skin and soft tissue exposure (48, 85, 152, 239, 247, 294, 296). Although noncapsular variants may arise through mutational events, there is evidence that capsule biosynthesis might be transcriptionally regulated (105). Through study of acapsular strains of P. multocida, a single-site mutation in the fis gene outside the cap locus was found to prevent capsule production despite the strains having an intact biosynthetic locus (432), suggesting that regulation of capsule production is possible through the Fis protein, a known transcriptional regulator in other bacteria. (iii) OMPs. Putative adhesins that enhance colonization by P. multocida have been reported (34, 433–442). OmpA is an outer membrane protein (OMP) that serves as an adhesin by binding to host extracellular matrix proteins, such as fibronectin (437, 438, 443). OmpH is a major outer membrane porin that forms a homotrimeric channel and has shown some potential as a protective antigen (444). OmpH and Pasteurella lipoprotein E (PlpE) are protective surface antigens associated with P. multocida serotype A:1, A:3, and A:4 strains isolated from cattle with shipping fever (445, 446) and from birds with fowl cholera (416). OmpA and OmpH proteins show considerable heterogeneity, and at least among avian P. multocida strains, a number of different variants appear to be associated with certain capsular serotypes (B, D, or F) (200, 227). Oma87, an 87-kDa outer membrane protein present in all P. multocida strains that is expressed in vivo, shares sequence similarity with the surface D15 protective surface antigen of H. influenzae (447). Another protective surface antigen that has been identified is a 39-kDa adhesion protein (Cp39) present in avian P. multocida strains P-1059 (serotype A:3) and X-73 (serotype A:1) (436, 448). The type IV fimbrial subunit PtfA has been identified and characterized from serotype A, B, D, and F strains (439, 449–451); however, the role of type IV fimbriae in adhesion, host specificity, and colonization is not yet clear. On the other hand, an analogous type IV pilin protein, Tfp, of Pseudomonas aeruginosa has been shown to bind lung epithelial cells, leading to pathogenic effects in the host (452). Growth of P. multocida strains under iron-limited versus iron-rich conditions showed iron-dependent changes in iron acquisition genes (413, 414), several of which were identified as encoding OMPs (453). Further insights about the role of these iron acquisition OMPs in the pathogenic potential of P. multocida could be gained by more comprehensive outer membrane proteomic analysis of these proteins in response to various iron and nutrient conditions. Despite all these reports and studies showing their potential use as protective antigens for component vaccines (see below), no OMP has yet been shown to be an essential virulence factor. (iv) Filamentous hemagglutinin. P. multocida possesses two filamentous hemagglutinins, FhaB1 and FhaB2 (also named PfhB1 and PfhB2, respectively) (70, 412). These proteins are similar to the LspA1 and LspA2 filamentous hemagglutinins from H. ducreyi (454), mutations of which have been shown to affect virulence (455). A similar filamentous hemagglutinin in Bordetella pertussis and B. bronchiseptica is required for biofilm formation and colonization of the nose and trachea in mice (456, 457). FhaB2 in P. multocida has been implicated in virulence (70, 458), and expression of FhaB2 was found to be reduced by 4-fold in a nonmucoid P. multocida variant, AL1114 (432). FhaB and its transporter FhaC form a two-partner secretion system that is similar to the FhaB-FhaC system in Bordetella species (456, 459), LspA-LspB in H. ducreyi (455), and IbpA-IbpB in the pathogenic Histophilus somni strain 2336 (460), which act to inhibit phagocytosis. Genome-wide comparison showed that the IbpA-IbpB system and two other immunoglobulin-binding proteins, p76 and p120, are absent in the avirulent H. somni strain PT129 (460). PMT. Once it was discovered that only certain capsular serotype D and A strains of P. multocida were responsible for chronic turbinate atrophy, a large protein toxin was identified, isolated, and cloned from these strains (148, 194, 196, 461, 462). The purified, 146kDa P. multocida toxin (PMT), encoded by the toxA gene located on a putative lysogenic bacteriophage (463), was subsequently demonstrated to be the primary agent responsible for the symptoms of atrophic rhinitis (461, 464–471), as well as a number of other clinical symptoms associated with P. multocida infection (189, 190, 192, 461, 464, 470, 472–475). PMT-mediated bone atrophy appears to occur through disruption of normal cell signaling processes in bone-generating osteoblasts and macrophage-like osteoclasts (205, 206, 466, 476–482). In humans, toxin-producing strains are often isolated from respiratory carriage or infections (483), but a role for PMT in human pulmonary disease has not yet been established. PMT is a member of the dermonecrotic toxin family of G-proteindeamidating toxins, whose molecular mechanism of action has been thoroughly reviewed (201, 484–487). Mounting evidence suggests that PMT enters mammalian cells (reviewed in reference 486) and exerts its pathogenic effect on cells through modulation of multiple signaling pathways (reviewed in reference 485). Recent studies have revealed that in addition to the α subunit of the heterotrimeric Gq protein (488–490), PMT also acts on other G proteins, i.e., G11, Gi, and G12/13 (488–494). A number of studies have implicated PMT as a modulator of host immunity (475, 495–498) and cellular differentiation and proliferation (476, 477, 485, 499–507). Interestingly, because of its potent mitogenic and Leading Article (Pasteurella multocida)
RkJQdWJsaXNoZXIy OTc5MDU=